Total Payments
$1.8M
2024 Payments
$447,741
Companies
46
Transactions
3,495
Medicare Patients
6,420
Medicare Billing
$576,669
Payment Breakdown by Category
Other$1.4M (75.9%)
Travel$216,394 (12.1%)
Consulting$145,182 (8.1%)
Food & Beverage$69,845 (3.9%)
Education$443.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.3M | 556 | 73.1% |
| Travel and Lodging | $216,394 | 596 | 12.1% |
| Consulting Fee | $145,182 | 61 | 8.1% |
| Food and Beverage | $69,845 | 2,250 | 3.9% |
| Honoraria | $43,181 | 20 | 2.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $7,360 | 3 | 0.4% |
| Education | $443.03 | 9 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $324,893 | 279 | $0 (2024) |
| Lilly USA, LLC | $215,533 | 426 | $0 (2024) |
| Celgene Corporation | $166,944 | 227 | $0 (2019) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $151,039 | 236 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $126,716 | 248 | $0 (2024) |
| ABBVIE INC. | $118,267 | 359 | $0 (2024) |
| Amgen Inc. | $117,759 | 135 | $0 (2024) |
| Janssen Biotech, Inc. | $105,424 | 275 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $85,423 | 123 | $0 (2024) |
| UCB, Inc. | $57,697 | 80 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $447,741 | 635 | ABBVIE INC. ($67,645) |
| 2023 | $314,245 | 536 | Lilly USA, LLC ($67,175) |
| 2022 | $200,757 | 546 | Sun Pharmaceutical Industries Inc. ($34,247) |
| 2021 | $146,622 | 347 | Janssen Scientific Affairs, LLC ($34,616) |
| 2020 | $92,384 | 156 | Janssen Scientific Affairs, LLC ($25,992) |
| 2019 | $184,844 | 419 | Janssen Scientific Affairs, LLC ($55,947) |
| 2018 | $242,124 | 475 | Janssen Scientific Affairs, LLC ($100,387) |
| 2017 | $163,891 | 381 | Janssen Scientific Affairs, LLC ($82,313) |
All Payment Transactions
3,495 individual payment records from CMS Open Payments — Page 1 of 140
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: Immunology | ||||||
| 12/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: Immunology | ||||||
| 12/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $39.06 | General |
| Category: Immunology | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Immunology | ||||||
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,380.00 | General |
| Category: Immunology | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Immunology | ||||||
| 12/12/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $183.82 | General |
| Category: Inflammation & Immunology | ||||||
| 12/12/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Inflammation & Immunology | ||||||
| 12/12/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $68.99 | General |
| Category: Immunology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $974.40 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $158.82 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | PFIZER INC. | CIBINQO (Drug) | Travel and Lodging | In-kind items and services | $142.50 | General |
| Category: Inflammation & Immunology | ||||||
| 12/10/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Travel and Lodging | Cash or cash equivalent | $115.67 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | PFIZER INC. | CIBINQO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,250.00 | General |
| Category: Inflammation & Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $114.34 | General |
| Category: Inflammation & Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: Dermatology | ||||||
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,194 | 3,930 | $471,960 | $203,598 |
| 2022 | 28 | 1,681 | 2,822 | $342,468 | $147,477 |
| 2021 | 26 | 1,592 | 2,904 | $323,600 | $144,198 |
| 2020 | 18 | 953 | 1,805 | $184,418 | $81,396 |
Total Patients
6,420
Total Services
11,461
Medicare Billing
$576,669
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 434 | 689 | $98,501 | $45,555 | 46.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 326 | 491 | $53,019 | $18,761 | 35.4% |
| 11301 | Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | Office | 2023 | 166 | 236 | $46,620 | $18,671 | 40.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 150 | $30,289 | $14,793 | 48.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 142 | 181 | $33,241 | $13,154 | 39.6% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 38 | 39 | $19,163 | $9,894 | 51.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 126 | 126 | $22,409 | $9,529 | 42.5% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 74 | 93 | $20,663 | $9,130 | 44.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 243 | 1,318 | $14,183 | $7,120 | 50.2% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 63 | 73 | $16,176 | $7,083 | 43.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 14 | $9,606 | $5,027 | 52.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 67 | 72 | $11,839 | $4,511 | 38.1% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 16 | 19 | $8,102 | $4,245 | 52.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,694 | $3,898 | 44.8% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 37 | 41 | $11,370 | $3,791 | 33.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 24 | 25 | $7,209 | $3,300 | 45.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 22 | 24 | $6,549 | $3,297 | 50.3% |
| 11306 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 32 | 32 | $6,377 | $2,830 | 44.4% |
| 11310 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less | Office | 2023 | 31 | 35 | $6,627 | $2,575 | 38.9% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $4,809 | $2,515 | 52.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 17 | 18 | $8,090 | $2,167 | 26.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 36 | 41 | $3,684 | $1,911 | 51.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 15 | $3,054 | $1,522 | 49.8% |
| 11307 | Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 13 | 15 | $3,382 | $1,492 | 44.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 11 | 12 | $4,738 | $1,478 | 31.2% |
About Dr. Stephen Hess, MD
Dr. Stephen Hess, MD is a Dermatology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1033279955.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Hess, MD has received a total of $1.8M in payments from pharmaceutical and medical device companies, with $447,741 received in 2024. These payments were reported across 3,495 transactions from 46 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.3M).
As a Medicare-enrolled provider, Hess has provided services to 6,420 Medicare beneficiaries, totaling 11,461 services with total Medicare billing of $576,669. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Philadelphia, PA
- Active Since 12/11/2006
- Last Updated 08/23/2013
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1033279955
Products in Payments
- Otezla (Drug) $269,955
- TREMFYA (Drug) $184,812
- Tremfya (Drug) $164,428
- DUPIXENT (Biological) $138,171
- ILUMYA (Biological) $123,017
- TALTZ (Drug) $106,218
- STELARA (Biological) $77,064
- Sotyktu (Drug) $75,370
- RINVOQ (Biological) $72,642
- OLUMIANT (Drug) $71,711
- Bimzelx (Biological) $50,368
- VTAMA (Drug) $49,366
- SKYRIZI (Biological) $42,718
- OPZELURA (Drug) $24,631
- DUPIXENT (Drug) $21,626
- CIBINQO (Drug) $20,563
- Ilumya (Biological) $17,973
- ADBRY (Biological) $15,823
- Zoryve (Drug) $15,137
- EUCRISA (Drug) $14,904
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Philadelphia
David Margolis, Md, MD
Dermatology — Payments: $1.1M
Dermatology $1.1M
Joel Gelfand, Md, MD
Dermatology — Payments: $787,044
Dermatology $787,044
Victoria Werth, Md, MD
Dermatology — Payments: $555,094
Dermatology $555,094
Dr. Harold Farber, M.d,, M.D,
Dermatology — Payments: $484,640
Dermatology $484,640
Dr. Lawrence Parish, Md, MD
Dermatology — Payments: $406,273
Dermatology $406,273
Dr. Jules Lipoff, Md, MD
Dermatology — Payments: $294,407
Dermatology $294,407